Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

Teva begins process of building new brand
Teva begins process of building new brand
JERUSALEM — Teva Pharmaceutical Industries announced Wednesday that it was starting the process of building a global brand via a corporate identity program that will span its enterprise.
Bayer Receives EU Approval of Kovaltry for Treatment of Hemophilia A
Bayer Receives EU Approval of Kovaltry for Treatment of Hemophilia A
Leverkusen, February 22, 2016 – Bayer has received approval from the European Commission of Kovaltry® for the treatment of hemophilia A in patients of all age groups.
Japanese company produces fastest vaccines using tobacco leaves
Japanese company produces fastest vaccines using tobacco leaves
Tokyo, Feb 23 (EFE).
OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer
OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer
TAIPEI, Taiwan, Feb.
Mylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association
Mylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association
HERTFORDSHIRE, England and PITTSBURGH, Feb.
Lannett Receives FDA Approval For Temozolomide Capsules
Lannett Receives FDA Approval For Temozolomide Capsules
Lannett Company, Inc.
Cipla EU completes $550m acquisition of US firms InvaGen and Exelan
Cipla EU completes $550m acquisition of US firms InvaGen and Exelan
Indian-based Cipla's UK division has completed the acquisition of InvaGen Pharmaceuticals and Exelan Pharmaceuticals in previously announced deals worth $550m.
US researchers develop 'mini-brains' to study neurological disorders
US researchers develop 'mini-brains' to study neurological disorders
Researchers at the Johns Hopkins Bloomberg School of Public Health, US, have developed 'mini-brains' to study neurological diseases.
CDC, Brazil start big study to test Zika link to birth defects
CDC, Brazil start big study to test Zika link to birth defects
U.
Zurampic (lesinurad) approved in the European Union for patients with gout
Zurampic (lesinurad) approved in the European Union for patients with gout
AstraZeneca today announced that the European Commission (EC) has granted marketing authorisation for ZurampicTM (lesinurad) 200mg in combination with a xanthine oxidase inhibitor (...
Teva offers EU concessions over Allergan generics deal
Teva offers EU concessions over Allergan generics deal
Teva Pharmaceutical Industries Ltd (TEVA.
World Bank Provides $150 Million to Combat Zika Virus In Latin America and the Caribbean
World Bank Provides $150 Million to Combat Zika Virus In Latin America and the Caribbean
WASHINGTON, February 18, 2016— In order to support countries in Latin America and the Caribbean affected by the Zika virus outbreak, the World Bank Group announced today that it has made US$150 mill...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand